Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short-term Effects of Dapagliflozin on Fasting and Postprandial Glucose Homeostasis in Male Type 1 Diabetes Patients.

NCT02211742 is registered in ClinicalTrials.gov with Medical University Innsbruck as lead sponsor.

NCT NCT02211742
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02211742 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short-term Effects of Dapagliflozin on Fasting and Postprandial Glucose Homeostasis in Male Type 1 Diabetes Patients.
Lead sponsor
Medical University Innsbruck
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2014
Completion date
February 8, 2017
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fasting glucose, glucose excursion, glycemic control